Table 1.
Characteristic of eligible adolescents living with perinatally-acquired HIV (APHIV) included in the COHADO cohort compared to those who were not included, during the inclusion period in Abidjan (Côte d'Ivoire), Lomé (Togo), IeDEA-pWADA, 2015–2017.
| Total | Not included in COHADO | Included in COHADO | P- Value | |
|---|---|---|---|---|
| N = 511 (%) | N = 302 (%) | N = 209 (%) | ||
| Site, n (%) | <0.01a | |||
| Abidjan (Côte d'Ivoire) | 371 (72.6) | 263 (87.1) | 108 (51.7) | |
| Lomé (Togo) | 140 (27.4) | 39 (12.9) | 101 (48.3) | |
| Sex, n(%) | 0.61a | |||
| Males | 239 (46.8) | 144 (47.7) | 95 (45.4) | |
| Females | 272 (53.2) | 158 (52.3) | 114 (54.6) | |
| Age in years, median [IQR] | 13 [11–15] | 14 [12–16] | 13 [11–15] | 0.06c |
| Age initiation ART, | ||||
| median [IQR] | 7[4–9] | 6[4–9] | 7[4–10] | 0.12c |
| WHO clinical stage | <0.01b | |||
| 1, 2, 3 | 380 (74.4) | 207 (68.5) | 173 (82.8) | |
| 4 (AIDS) | 43 (8.4) | 7 (2.3) | 36 (17.2) | |
| Missing | 88 (17.2) | 88 (29.4) | 0 (0.0) | |
| Virological suppression at last, n (%) | ||||
| (Viral load <50 cp/mL) | <0.01b | |||
| Yes | 34 (6.7) | 32 (10.6) | 2 (1.0) | |
| No | 190 (37.2) | 130 (43.0) | 60 (28.7) | |
| Missing | 287 (56.1) | 140 (46.4) | 147 (70.3) | |
| CD4, median [IQR] | 483 [258–701] | 487 [277–678] | 534 [278–798] | 0.76c |
a
Chi2 test;
b
Fisher's exact test;
c
Wilcoxon-Mann-Whitney test.